November 7, 2017 / 10:02 PM / 12 days ago

BRIEF-Syndax Pharmaceuticals reports Q3 loss per share $0.68

Nov 7 (Reuters) - Syndax Pharmaceuticals Inc:

* Syndax pharmaceuticals reports third quarter 2017 financial results and provides clinical and business update

* Q3 loss per share $0.68

* Q3 earnings per share view $-0.80 -- Thomson Reuters I/B/E/S Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below